Should mass screening for prostate cancer be introduced at the national level?
Davidson, P. and Gabbay, J. (2004) Should mass screening for prostate cancer be introduced at the national level? Copenhagen, Denmark, WHO Regional Office for Europe’s Health Evidence Network (HEN) (Health Evidence Network (HEN) Synthesis Report).
Full text not available from this repository.
Prostate cancer is a major cause of death among men, with over 56,000 deaths in the European Union
in 1998. There are no obvious preventive strategies, therefore screening has been considered to reduce
the number of deaths. Opportunistic screening is widely carried out but there are no known national
programmes to screen for prostate cancer.
There are no completed randomized screening trials, although two are underway. Evidence from nonrandomized
studies suggests possible benefit, but these results may not be reliable due to bias or
alternative explanations. The main areas of uncertainty are the natural history of the disease, which
appears relatively benign in many cases, and appropriate treatment for positive screened cases.
Mass screening should not be introduced at the national level, unless supportive evidence is available
from the ongoing screening or treatment trials.
|Item Type:||Monograph (Project Report)|
|Keywords:||prostatic neoplasms, mass screening, national health programs, health policy, decision support techniques|
|Subjects:||R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer)
R Medicine > RA Public aspects of medicine
|Divisions:||University Structure - Pre August 2011 > School of Medicine
|Date Deposited:||12 Sep 2008|
|Last Modified:||02 Mar 2012 13:55|
|Contributors:||Davidson, P. (Author)
Gabbay, J. (Author)
|Publisher:||WHO Regional Office for Europe’s Health Evidence Network (HEN)|
|RDF:||RDF+N-Triples, RDF+N3, RDF+XML, Browse.|
Actions (login required)